
Cardiac Insight
Privately held medical device company based in seattle, wa.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
$8.0m | Series D | ||
Total Funding | 000k |
Related Content
Cardiac Insight Inc. is a US-based medical device company that develops and commercializes body-worn sensing and computing technologies for cardiac diagnostic testing. The company's flagship product, the Cardea SOLO, is a lightweight, wearable, and water-resistant electrocardiogram (ECG) sensor that can be worn for up to seven days to detect and diagnose cardiac arrhythmias. The Cardea SOLO system also includes a software component that allows physicians to analyze the collected data and generate reports.
Cardiac Insight primarily serves cardiologists, electrophysiologists, and other healthcare professionals who diagnose and treat patients with cardiac conditions. The company's products are used in a variety of settings, including hospitals, clinics, and private practices. The company operates in the cardiac monitoring market, which is a large and growing segment of the medical device industry. Cardiac Insight's business model is based on the sale of its Cardea SOLO sensors and software, as well as recurring revenue from the sale of disposable electrodes and other consumables.
Keywords: cardiac diagnostics, medical devices, wearable sensors, ECG monitoring, arrhythmia detection, digital health, cardiology, remote patient monitoring, healthcare technology, medical technology
Tech stack
Investments by Cardiac Insight
Edit